Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs 4 Hydroxyphenylpyruvic Aciduria C1848678
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and 4 Hydroxyphenylpyruvic Aciduria for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
4 Hydroxyphenylpyruvic Aciduria C1848678
A metabolic disorder involving difficulty processing tyrosine, an amino acid. Can affect development and growth. Treatment focuses on dietary management and supportive care.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
4 Hydroxyphenylpyruvic Aciduria C1848678
0-5
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
4 Hydroxyphenylpyruvic Aciduria C1848678
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
4 Hydroxyphenylpyruvic Aciduria C1848678
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
4 Hydroxyphenylpyruvic Aciduria C1848678
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
4 Hydroxyphenylpyruvic Aciduria C1848678
metabolic
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
4 Hydroxyphenylpyruvic Aciduria C1848678
metabolic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and 4-hydroxyphenylpyruvic-aciduria-C1848678 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 4 Hydroxyphenylpyruvic Aciduria C1848678 | Discriminating power |
|---|---|---|---|
| Genital development | Undervirilization may occur in 46,XY individuals. | No established genital-development pattern is supplied. | High |
| Growth and development | Primary developmental effects are not established by the source. | Development and growth may be affected. | Moderate |
| Metabolic features | The described problem is androgen synthesis, not tyrosine processing. | Difficulty processing tyrosine is the central description. | High |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY undervirilization
The source links this pattern to isolated 17,20-lyase deficiency.
Moderate
Suspected androgen-synthesis disorder
The enzyme is described as needed for androgen synthesis.
Moderate
Endocrine reproductive evaluation
The supplied category and body system point toward endocrine and reproductive assessment.
Low
Choose 4 Hydroxyphenylpyruvic Aciduria C1848678 when
Tyrosine-processing concern
The source specifically describes difficulty processing tyrosine.
Moderate
Abnormal organic-acid finding
Aciduria denotes a laboratory abnormality and needs diagnostic confirmation.
Moderate
Growth or developmental concern
The source says development and growth can be affected.
Low
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 4 Hydroxyphenylpyruvic Aciduria C1848678 | Interpretation |
|---|---|---|---|
| Steroid or androgen evaluation | May be considered because androgen synthesis is impaired. | Not specifically indicated by the supplied description. | No cutoff is established here; specialist interpretation is required. |
| Urine organic-acid analysis | No characteristic result is supplied. | May show 4-hydroxyphenylpyruvic acid, but this is an abnormal finding rather than a diagnosis. | Confirm the result and clinical context before assigning a metabolic disorder. |
| Tyrosine-pathway assessment | Not described as relevant by the source. | May be relevant to tyrosine processing. | Exact laboratory thresholds are not provided and should not be inferred. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- Chronic and described as severe, but individual outcome is not established.
- Factors
- Degree of undervirilization and response to specialist hormone management may matter.
4 Hydroxyphenylpyruvic Aciduria C1848678
- Outcome
- Chronic and described as moderate, with possible effects on growth and development.
- Factors
- Tyrosine-processing difficulty and response to dietary and supportive care may matter.
Time frame: Both are described as chronic; exact timelines are not supplied.
Prognosis should be individualized because outcome data are not provided.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization | Described as a consequence in affected 46,XY individuals. Not established by the source. Severity and phenotype can vary; clinician assessment is needed. |
| Developmental effects | Not specifically established beyond the reproductive description. Development and growth can be affected. The source does not define which developmental outcomes occur. |
| Long-term management burden | Hormone therapy is described as management. Dietary management and supportive care are described. No doses, diet targets, or outcome rates are established here. |
Patient education highlights
- HighDifferent conditions
These conditions involve different systems and should not be treated as interchangeable.
- HighSpecialist confirmation
An abnormal result or suggestive feature needs clinician and specialist interpretation.
- MediumManagement approach
Hormone therapy or dietary and supportive care may be discussed, but individualized plans are required.